Clinical Trial Update: Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating personalized spacing of eculizumab infusions guided by therapeutic pharmacological monitoring in atypical hemolytic uremic syndrome h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Hemolytic-Uremic Syndrome, Atypical | Phase 3 | Status: COMPLETED